Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
SMO protein inhibitor
DRUG CLASS:
SMO protein inhibitor
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
IPI 926 oral (2)
glasdegib (1)
BMS-833923 (0)
ZSP1602 (0)
SGT-610 (0)
ENV 101 (0)
IPI 926 oral (2)
glasdegib (1)
BMS-833923 (0)
ZSP1602 (0)
SGT-610 (0)
ENV 101 (0)
›
Associations
(5)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Acute Myelogenous Leukemia
No biomarker
Acute Myelogenous Leukemia
glasdegib
Sensitive: A1 - Approval
glasdegib
Sensitive
:
A1
glasdegib
Sensitive: A1 - Approval
glasdegib
Sensitive
:
A1
PTCH1 deletion
Medulloblastoma
PTCH1 deletion
Medulloblastoma
IPI 926 oral
Sensitive: D – Preclinical
IPI 926 oral
Sensitive
:
D
IPI 926 oral
Sensitive: D – Preclinical
IPI 926 oral
Sensitive
:
D
SUFU mutation
Medulloblastoma
SUFU mutation
Medulloblastoma
SMO protein inhibitor
Resistant: D – Preclinical
SMO protein inhibitor
Resistant
:
D
SMO protein inhibitor
Resistant: D – Preclinical
SMO protein inhibitor
Resistant
:
D
PTCH1 mutation
Medulloblastoma
PTCH1 mutation
Medulloblastoma
SMO protein inhibitor
Sensitive: D – Preclinical
SMO protein inhibitor
Sensitive
:
D
SMO protein inhibitor
Sensitive: D – Preclinical
SMO protein inhibitor
Sensitive
:
D
SMO D473H
Medulloblastoma
SMO D473H
Medulloblastoma
IPI 926 oral
Sensitive: D – Preclinical
IPI 926 oral
Sensitive
:
D
IPI 926 oral
Sensitive: D – Preclinical
IPI 926 oral
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.